ENST00000379989.6:c.2927C>T
Variant summary
Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BS1BP4BP2
This summary comes from the ClinGen Evidence Repository: The allele frequency of the p.Pro976Leu variant in CDKL5 is 0.01% in South Asian sub population in gnomAD, which is high enough to be classified as likely benign based on thresholds defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like conditions (BS1). The p.Pro976Leu variant is observed in the CDKL5 gene where a second pathogenic variant in the same gene is present in the patient (internal database) (BP2). Computational analysis prediction tools suggest that the p.Pro976Leu variant does not have a deleterious impact; however this information does not predict clinical significance on its own (BP4). In summary, the p.Pro976Leu variant in CDKL5 is classified as likely benign based on the ACMG/AMP criteria (BS1, BP2, BP4). LINK:https://erepo.genome.network/evrepo/ui/classification/CA171640/MONDO:0100039/016
Frequency
Consequence
ENST00000379989.6 missense
Scores
Clinical Significance
Conservation
Publications
- retinoschisisInheritance: XL Classification: DEFINITIVE Submitted by: G2P
- X-linked retinoschisisInheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae), Myriad Women’s Health, ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -6 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| RS1 | NM_000330.4 | c.185-3207G>A | intron_variant | Intron 3 of 5 | ENST00000379984.4 | NP_000321.1 | ||
| CDKL5 | NM_001037343.2 | c.2927C>T | p.Pro976Leu | missense_variant | Exon 21 of 22 | NP_001032420.1 | ||
| CDKL5 | NM_003159.3 | c.2927C>T | p.Pro976Leu | missense_variant | Exon 20 of 21 | NP_003150.1 | ||
| RS1 | XM_047442337.1 | c.-156G>A | 5_prime_UTR_variant | Exon 1 of 4 | XP_047298293.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000267 AC: 3AN: 112533Hom.: 0 Cov.: 24 show subpopulations
GnomAD2 exomes AF: 0.0000436 AC: 8AN: 183387 AF XY: 0.0000295 show subpopulations
GnomAD4 exome AF: 0.0000392 AC: 43AN: 1098034Hom.: 0 Cov.: 30 AF XY: 0.0000468 AC XY: 17AN XY: 363392 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000267 AC: 3AN: 112533Hom.: 0 Cov.: 24 AF XY: 0.00 AC XY: 0AN XY: 34705 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Benign:3
This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
- -
In exon 20, only affects original isoforms; In silico prediction: SIFT = tolerated, MutationTaster = polymorphism, PolyPhen2 = benign, AlignGVGD = benign (C0) -
CDKL5 disorder Benign:2
This variant has been collected from RettBASE and curated to current modified ACMG/AMP criteria. Based on the classification scheme defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like Disorders Specifications to the ACMG/AMP Variant Interpretation Guidelines VCEP 3.0, this variant is classified as likely benign. At least the following criteria are met: The allele frequency of this variant in at least one population in gnomAD is between 0.008% and 0.03% (BS1). Computational prediction analysis tools suggest no impact on gene product (REVEL score <= 0.15) (BP4). -
The allele frequency of the p.Pro976Leu variant in CDKL5 is 0.01% in South Asian sub population in gnomAD, which is high enough to be classified as likely benign based on thresholds defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like conditions (BS1). The p.Pro976Leu variant is observed in the CDKL5 gene where a second pathogenic variant in the same gene is present in the patient (internal database) (BP2). Computational analysis prediction tools suggest that the p.Pro976Leu variant does not have a deleterious impact; however this information does not predict clinical significance on its own (BP4). In summary, the p.Pro976Leu variant in CDKL5 is classified as likely benign based on the ACMG/AMP criteria (BS1, BP2, BP4). -
Developmental and epileptic encephalopathy, 2;CN128785:Angelman syndrome-like Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at